StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Lobbying to Benefit Novartis - Essay Example

Cite this document
Summary
The paper "Lobbying to Benefit Novartis" discusses that monetary and fiscal policies can have a significant impact on the business operations of any firm. These policies can not only affect the top line (revenue) of the firm but also several costs and most definitely the bottom line…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER97.2% of users find it useful
Lobbying to Benefit Novartis
Read Text Preview

Extract of sample "Lobbying to Benefit Novartis"

Novartis is a pharmaceutical company (operating in 140 countries) headquartered in Basel, Switzerland, and does most of its research and development (R&D) activity in the US. According to the annual report of Novartis for 2010, some key points to note are:

1. Sales from recently launched products (after 2007) account for 21% of the total revenue – one of the highest for pharmaceutical companies.
2. Novartis has 5 different operating segments: Pharmaceuticals, Vaccines and diagnostics, Sandoz (generics sales), Consumer Health (OTC sales, and animal health), and Alcon (eye care). Pharmaceuticals account for 60% of the sales and are highly profitable but the Vaccines and diagnostics segment is the most profitable.
3. Sales in the US account for 33% of sales, Europe 39%, Asia and Africa 20%, and the rest of America 9%.
4. Tax on profit for Novartis was nearly 15% for both 2009 and 2010.

Other than this, the important facts to keep in mind about Novartis’ business are that it is largely driven by government spending on healthcare and that in 2010 Novartis invested 16% of its revenues (net sales) into R&D for new products – one of the highest in the pharmaceutical industry. Novartis has 27,466 employees in the US compared to 119,418 worldwide (as of the end of 2010).
As a lobbyist in the US for Novartis, I would focus on government spending policy (in the healthcare sector), on changes in taxation policy for healthcare products and for pharmaceutical R&D, and on special treatment in terms of duty or taxes of certain medicines that Novartis imports into and/or exports from the US.

Novartis’ business is largely driven by the government’s policy on public healthcare spending. As the government is facing higher pressure on the healthcare cost, they are forcing Novartis and other pharmaceutical companies to reduce their prices resulting in reduced margins for the companies. To get a favorable position for Novartis, I would lobby for exclusions for certain high-value and high-profit drugs (patented drugs mainly) for Novartis from price reduction while having compensatory price reductions on other large volume drugs which are anyways competitive and would affect the competition equally in terms of price.

For taxation policy, I would lobby for the government to change its taxation policy for pharmaceutical products, especially for patented drugs. Novartis has most of its profitable business from patent drugs and once the patent expires, generics enter the market with low-priced products. So, I would lobby for the government to reduce taxes on patented drugs and to increase taxes on generic drugs so that the patented drugs can become less costly and more affordable for the people while making the generics less competitive by having to pay higher taxes. Also, I would lobby for a reduction of taxes on OTC and animal health products as this segment is the most profitable for Novartis. Lower taxes would attract higher sales, and as the government does not need to compensate OTC sales either, it would be a win-win proposition.

Further, as Novartis is heavy on making R&D investments, I would lobby for the government to further reduce the corporate tax policy for Novartis in the US with a promise from Novartis to increase its workforce in exchange for this lower tax rate. Going by the trend, Novartis is expected to increase employment in the US due to increasing investment in R&D and the fact that most research is done in the US, Novartis would benefit from lower taxes against the promise of hiring more employees, which it would naturally do in any case.
As Novartis is a global organization, it certainly imports certain drugs into the US and exports some others out of the US; I would thus lobby for the reduction of government tariffs on the import of certain drug types so that the landed cost for Novartis these products can be reduced. At the same time, better export incentives for good value-added pharmaceutical drugs would reduce the cost of Novartis products in other countries. Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“ECO202 SLP Essay Example | Topics and Well Written Essays - 500 words”, n.d.)
Retrieved from https://studentshare.org/other/1424900-eco202-slp
(ECO202 SLP Essay Example | Topics and Well Written Essays - 500 Words)
https://studentshare.org/other/1424900-eco202-slp.
“ECO202 SLP Essay Example | Topics and Well Written Essays - 500 Words”, n.d. https://studentshare.org/other/1424900-eco202-slp.
  • Cited: 0 times

CHECK THESE SAMPLES OF Lobbying to Benefit Novartis

The Company Novartis

The company novartis Technology factor The company novartis successfully presented the medicine for patients with brain tumour.... novartis also held a number of successful trials testing medicine that was created to cure Fragile X Syndrome.... Therefore, novartis is famous for the Central Nervous System Segment.... Instead of concentrating the attention mostly on medicines, which can be sold in large markets, novartis' experts are analyzing rare illnesses with the purpose of using the findings also for common diseases....
4 Pages (1000 words) Essay

Antitrust Practices and Market Power

Famous pharmaceutical giants like Glaxo, Ranbaxy, and novartis enjoy imperfect powers in the pharmaceutical industry.... It is also found that Google introduces lobbying affairs with smartphone makers and forces them not to remove the Google android operating systems from their manufactured phones....
5 Pages (1250 words) Essay

Information Technological Change and Innovation

irms and public policy of technology changeFirms have played a major role in actively lobbying for greater technology advancement, with mixed results.... In some cases, like American semiconductor companies lobbying for massive government financial support in the 1980s for R&D collaboration, the effort failed because private firms refused to collaborate in an industry marked by the preservation of competitive...
13 Pages (3250 words) Essay

Syngenta and GM crops

LONDON – Syngenta AG, the global Swiss multinational agribusiness corporation, is being sued by farmers groups because of its use of genetically-modified organisms (GMO) technology in the production and distribution of corn seeds.... In particular, the United States Department of.... ... ... Agriculture (USDA) had previously approved its use for the production of a type of ethanol (Enogen) only but not for corn production intended for export....
4 Pages (1000 words) Article

The Economic Implications of Gender Based Discrimination at the Workplace

Generally, we categorize five types of discrimination taking place in the workplace.... This includes race, sex or gender, religion, age, and disability.... This paper will focus on gender or also known as sexual discrimination, its causes and its effects on the economy.... ... ... ... All the actions of economists have been geared towards achieving the economic goals....
11 Pages (2750 words) Term Paper

Merck and Co Incorporated

Merck has a major competitive threat from GlaxoSmithKline plc, novartis AG and Pfizer Inc.... This paper "Merck and Co Incorporated" undertakes critical strategic analysis about a pharmaceutical company with its headquarters in New Jersey, USA.... The pharmaceutical industry has been hit significantly by healthcare bills, interest rate, and currency changes, alternatives for social care....
10 Pages (2500 words) Case Study

Global Talent Management at Novartis

The paper 'Global Talent Management at novartis" is a good example of a management case study.... This report discusses the various issues of talent management at novartis.... The paper 'Global Talent Management at novartis" is a good example of a management case study.... This report discusses the various issues of talent management at novartis.... The paper 'Global Talent Management at novartis" is a good example of a management case study....
8 Pages (2000 words) Case Study

Global Talent Management in Novartis

This paper "Global Talent Management in novartis" discusses that talent management encompasses everything a company does in developing, retaining, recruiting and performance management.... Overall, matching pay for performance, as shown in novartis's compensation plan, ensures a standardized approach to evaluating employees.... In novartis, for instance, the payout is matched based on the expectations of each role, division and department.... novartis approaches matching of pay to performance by adopting a uniform pay-for-performance measurement system or approach used worldwide....
6 Pages (1500 words) Assignment
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us